CRYPTO:INJUSD

Injective Usd Stock News

etoro logo Buy INJUSD
*Your capital is at risk
$6.40
-0.110 (-1.69%)
At Close: Jun 03, 2026
Injective (INJ) trades at $2.87 with neutral RSI at 41.91. Technical analysis suggests potential recovery to $3.19 resistance within one week as INJ approaches oversold territory.
INJ Price Prediction Summary • Short-term target (1 week): $3.15 • Medium-term forecast (1 month): $3.25-$3.50 range • Bullish breakout level: $3.09 • Critical support: $2.
Injective (INJ) trades at $2.90 with neutral RSI at 42.01. Technical analysis suggests potential rally to $3.26 resistance if INJ breaks above $2.98 pivot level within 2-3 weeks.
INJ Price Prediction Summary • Short-term target (1 week): $3.05 • Medium-term forecast (1 month): $3.20-$3.26 range • Bullish breakout level: $3.26 • Critical support: $2.
Injective (INJ) trades at $2.96 with neutral RSI at 43.92. Technical analysis suggests potential upside to $3.19 resistance level, with critical support holding at $2.85.
INJ shows neutral momentum at $3.11 with 49.78 RSI. Technical analysis suggests potential move to $3.28 Bollinger Band resistance, though bearish MACD signals caution for Injective price prediction.
Injective trades at $3.05 with RSI at 47.36 in neutral territory. Technical analysis suggests potential test of $3.17 resistance within one week if momentum builds.
Altcoins have seen a sharp decline in trading activity, with volumes dropping nearly 80% to 85% as market volatility remains concentrated in a few major tokens. Interest has also cooled, reflected in
INJ Price Prediction Summary • Short-term target (1 week): $2.99-$3.05 • Medium-term forecast (1 month): $3.15-$3.30 range • Bullish breakout level: $3.27 • Critical support: $2.
INJ trades at $2.98 with neutral RSI at 43.92. Technical analysis points to $3.22 resistance breakout potential, though bearish MACD suggests caution for short-term recovery.
Injective (INJ) shows neutral momentum at $3.09 with key resistance at $3.24. Technical analysis suggests upside to $3.50 in coming weeks if bulls reclaim control.
Injective said on Tuesday that it plans to integrate USD Coin (USDC) and Circle's Cross-Chain Transfer Protocol (CCTP), aiming to expand stablecoin liquidity and enable native cross-chain transfers on
TL;DR: Injective announced it will integrate native USDC and Circle's CCTP protocol for cross-chain transfers without relying on third-party bridges. USDC supply is approaching $80 billion, up 42% fro
Circle (CRCL) stock climbs 2.83% following USDC's launch on Injective. Native issuance eliminates reliance on vulnerable bridged token solutions.
Injective will support native issuance of USDC through an integration with Circle's Cross-Chain Transfer Protocol. The integration will allow users to transfer USDC across supported blockchains withou
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE